批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/01/13 |
SUPPL-40(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/07/06 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/02/05 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/02/01 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/12/16 |
SUPPL-32(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/04/25 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/07/17 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/02/20 |
SUPPL-26(补充) |
Approval |
Labeling |
|
|
|
2007/07/11 |
SUPPL-25(补充) |
Approval |
Labeling |
|
|
|
2005/10/06 |
SUPPL-21(补充) |
Approval |
Labeling |
|
|
|
2000/11/07 |
SUPPL-18(补充) |
Approval |
Labeling |
|
|
|
1998/04/03 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/02/05 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/06/28 |
SUPPL-15(补充) |
Approval |
Labeling |
|
|
|
1994/03/31 |
SUPPL-11(补充) |
Approval |
Labeling |
|
|
|
1994/03/31 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1993/09/29 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1993/05/28 |
SUPPL-13(补充) |
Approval |
Labeling |
|
|
|
1989/08/16 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1989/06/12 |
SUPPL-8(补充) |
Approval |
Labeling |
|
|
|
1989/04/26 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1988/04/19 |
SUPPL-5(补充) |
Approval |
Labeling |
|
|
|
1988/04/08 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1988/04/08 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1987/04/13 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1987/04/13 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1986/12/10 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE 剂型/给药途径:TABLET;ORAL 规格:EQ 25MG BASE;10MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
071297 |
001 |
ANDA |
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE |
AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE |
TABLET;ORAL |
EQ 25MG BASE;10MG |
Prescription |
No |
Yes |
AB |
1986/12/10
|
MYLAN PHARMS INC |
211925 |
002 |
ANDA |
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE |
AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE |
TABLET;ORAL |
EQ 25MG BASE;10MG |
Prescription |
No |
No |
AB |
2022/02/02
|
MICRO LABS |
活性成分:AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE 剂型/给药途径:TABLET;ORAL 规格:EQ 12.5MG BASE;5MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
071297 |
002 |
ANDA |
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE |
AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE |
TABLET;ORAL |
EQ 12.5MG BASE;5MG |
Prescription |
No |
No |
AB |
1986/12/10
|
MYLAN PHARMS INC |
211925 |
001 |
ANDA |
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE |
AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE |
TABLET;ORAL |
EQ 12.5MG BASE;5MG |
Prescription |
No |
No |
AB |
2022/02/02
|
MICRO LABS |